Kyverna Therapeutics Announces the Appointment of James Chung, M.D., Ph.D., as Chief Medical Officer
- Tuesday, April 13, 2021, 7:05
- Finance
- Add a comment
EMERYVILLE, Calif., April 13, 2021 /PRNewswire/ — Kyverna Therapeutics (“Kyverna”), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced the appointment of James Chung, M.D., Ph.D., as the Company’s first Chief Medical Officer. Dr….
About the Author
adminasapcorp has written 41828 stories on this site.